ID

26173

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: End of study Survival status

Mots-clés

  1. 10/10/2017 10/10/2017 -
  2. 16/10/2017 16/10/2017 -
  3. 23/10/2017 23/10/2017 -
  4. 11/01/2018 11/01/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

10 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

Assessment date
Description

Assessment date

1. Most recent survival status assessment
Description

Most recent survival status assessment

Type de données

date

Survival data
Description

Survival data

1. Subject status
Description

Subject status

Type de données

integer

If subject known to be alive: Subject known to be alive on (date)
Description

Date Subject known to be alive

Type de données

date

If subject known to be alive: Source of information
Description

Subject alive Source of information

Type de données

text

If subject known to be alive: Other source of information, specify
Description

Subject alive Source of information specification

Type de données

text

If subject died: date that site acquired death information
Description

date that site acquired death information

Type de données

date

If subject died: Source of information
Description

death of subject Source of information

Type de données

text

If subject died: Other source of information, specify
Description

Subject dead Source of information specification

Type de données

text

Similar models

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Assessment date
Most recent survival status assessment
Item
1. Most recent survival status assessment
date
Item Group
Survival data
Item
1. Subject status
integer
Code List
1. Subject status
CL Item
Subject known to be alive (1)
CL Item
Subject died (2)
Date Subject known to be alive
Item
If subject known to be alive: Subject known to be alive on (date)
date
Item
If subject known to be alive: Source of information
text
Code List
If subject known to be alive: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (3)
CL Item
Other (OT)
CL Item
Investigative site staff (4)
CL Item
Friend or neighbor (5)
Item
If subject known to be alive: Other source of information, specify
text
Code List
If subject known to be alive: Other source of information, specify
date that site acquired death information
Item
If subject died: date that site acquired death information
date
Item
If subject died: Source of information
text
Code List
If subject died: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (3)
CL Item
Other (OT)
CL Item
Investigative site staff (4)
CL Item
Friend or neighbor (5)
Subject dead Source of information specification
Item
If subject died: Other source of information, specify
text

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial